BiotechReality – Covering Industry, Business, and Academia
Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.
Researchers controlled inflammation from multiple sclerosis in mice by programming immune cells to target glioblastoma. There will soon be a clinical trial to test the glioblastoma technique.
Journal Updates
18 April 2024
Research establishes foundation for clinical experiment targeted at averting brain tumours in kids with NF1.
A SciRealityPress Associate
Contents in the website is licensed under CC BY-NC 4.0
Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio